Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
Lancet. 1994 Oct 22;344(8930):1125-7. doi: 10.1016/s0140-6736(94)90632-7.
Lancet. 1994.
PMID: 7934495
Clinical Trial.